CagriSema: Two Molecules, Complementary Mechanisms CagriSema combines two existing molecules in a fixed-dose injection
You get 24/7 clinician access and ongoing support
While the exact mechanisms are unclear, researchers believe GLP-1 drugs may help by reducing brain inflammation, improving insulin resistance, and aiding in clearing amyloid-beta plaquesprotein buildups linked to Alzheimers progression
In obesity progression, PQQ mitigates mitochondrial dysfunction and obesity-associated inflammation, resulting in the amelioration of the progression of obesity co-morbidities, including non-alcoholic fatty liver disease, chronic kidney disease, and Type 2 diabetes
For adults, take three (3) teaspoons (15 mL in dose cup) with a meal, two times daily
Watch closely for changes in your health, and be sure to contact your doctor or nurse advice line if you have any problems